Conclusion: Once daily Arikace demonstrated acute ability, safety and efficacy in paitients with CF. This is the beginning and we should get "News Release" tomorrow.
Best wishes and thanks to "blank2thisone"
Well I have my eye on $18 but if this is true, I think I'm undershooting. Well the charts show $18 but news trumps charts and this kind of news can bring us to $22 fast, say Jan.?
Sentiment: Strong Buy
4.5 million shares need to cover. The more it rises without covering the more upward pressure it puts on the SP. At some point the momentum players will also show up. Then it gets really interesting.
I don't see anything there which hasn't previously been posted in this forum. But one suspects that the thumbs-down ratings are being allocated by somebody with a serious personality disorder, whose life sucks to such an extent that he draws comfort from the belief that his thumbs-down ratings irritate others.
I'm guessing that for the individual in question, being despised is preferable to not being noticed.